Papandreou C, Bulló M, Ruiz-Canela M, et al. Plasma metabolites predict both insulin resistance and incident type 2 diabetes: a metabolomics approach within the Prevención con Dieta Mediterránea (PREDIMED) study. The American journal of clinical nutrition. 2019;109(3):626-634. doi:10.1093/ajcn/nqy262
Metabolomics Platform
Chaffin MD, Cao L, Deik AA, et al. MetProc: Separating Measurement Artifacts from True Metabolites in an Untargeted Metabolomics Experiment. Journal of proteome research. 2019;18(3):1446-1450. doi:10.1021/acs.jproteome.8b00893
Papandreou C, Li J, Liang L, et al. Metabolites related to purine catabolism and risk of type 2 diabetes incidence; modifying effects of the TCF7L2-rs7903146 polymorphism. Scientific reports. 2019;9(1):2892. doi:10.1038/s41598-019-39441-6
Rhee EP, Waikar SS, Rebholz CM, et al. Variability of Two Metabolomic Platforms in CKD. Clinical journal of the American Society of Nephrology : CJASN. 2019;14(1):40-48. doi:10.2215/CJN.07070618
Beger RD, Dunn WB, Bandukwala A, et al. Towards quality assurance and quality control in untargeted metabolomics studies. Metabolomics : Official journal of the Metabolomic Society. 2019;15(1):4. doi:10.1007/s11306-018-1460-7
Murphy RA, Moore S, Playdon M, et al. Metabolites Associated With Risk of Developing Mobility Disability in the Health, Aging and Body Composition Study. J Gerontol A Biol Sci Med Sci. 2019;74(1):73-80. doi:10.1093/gerona/glx233
Yeri A, Murphy RA, Marron MM, et al. Metabolite Profiles of Healthy Aging Index Are Associated With Cardiovascular Disease in African Americans: The Health, Aging, and Body Composition Study. J Gerontol A Biol Sci Med Sci. 2019;74(1):68-72. doi:10.1093/gerona/glx232
Gelaye B, Clish CB, Denis M, et al. Metabolomics signatures associated with an oral glucose challenge in pregnant women. Diabetes Metab. 2019;45(1):39-46. doi:10.1016/j.diabet.2018.01.004
Xu JZ, Garrett ME, Soldano KL, et al. Clinical and metabolomic risk factors associated with rapid renal function decline in sickle cell disease. Am J Hematol. 2018;93(12):1451-1460. doi:10.1002/ajh.25263
Razquin C, Toledo E, Clish CB, et al. Plasma Lipidomic Profiling and Risk of Type 2 Diabetes in the PREDIMED Trial. Diabetes Care. 2018;41(12):2617-2624. doi:10.2337/dc18-0840